GKSL NSE filing

Gujarat Kidney And Superspeciality Limited Submits SEBI Compliance Certificate

The RealCase readLow impact Neutral

Gujarat Kidney And Superspeciality Limited submitted a SEBI compliance certificate for the quarter ended March 31, 2026. The certificate confirms all shares are in electronic form, with no physical holdings. The submission was made on April 7, 2026.

Why it matters

This is a standard compliance filing related to share dematerialization and does not involve any material business or financial developments.

The market read

The announcement is a routine regulatory filing and does not contain any information that would positively or negatively impact the company's stock.

Gujarat Kidney And Superspeciality Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, to BSE Limited and the National Stock Exchange of India Limited.

This certificate, received from M/s. MUFG Intime India Private Limited (the Company's Registrar and Share Transfer Agents), confirms that all shares have been issued in electronic form and there is no holding in physical form for the quarter ended March 31, 2026.

The company has requested that this information be taken on record and disseminated on the stock exchanges' websites. The submission was made on April 7, 2026.

Filing to action

What to do with a filing like this

Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.

View original filing